COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1884: Articles 18831-18840  | Next

Incidence and Relative Risk of infection with SARS-CoV-2 virus (Covid-19) in European Soccer Players.
Andersen, T. B., Dahl, A. B., Carstensen, J. B.
10.1101/2021.01.19.21250085 — Posted: 2021-01-20 Discussion: Onsite
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru.
Alvarez-Antonio, C., Meza-Sanchez, G., Calampa, C., Casanova, W., Carey, C., Alava, F., Rodriguez-Ferrucci, H., Quispe, A. M.
10.1101/2021.01.17.21249913 — Posted: 2021-01-20
Epidemic waves of COVID-19 in Scotland: a genomic perspective on the impact of the introduction and relaxation of lockdown on SARS-CoV-2
Lycett, S. J., Hughes, J., McHugh, M. P., Filipe, A. D. S., Dewar, R., Lu, L., Doherty, T., Shepherd, A., Inward, R., Rossi, G., Balaz, D., Kao, R. R., Rooke, S., Cotton, S., Gallagher, M. D., Balcazar-Lopez, C. E., O'Toole, A., Scher, E., Hill, V., McCrone, J. T., Colquhoun, R. M., Jackson, B., Williams, T. C., Williamson, K. A., Johnson, N., Smollett, K., Mair, D., Carmichael, S., Tong, L., Nichols, J., Brunker, K., Shepherd, J. G., Li, K., Aranday-Cortes, E., Parr, Y. A., Broos, A., Nomikou, K., McDonald, S. E., Niebel, M., Asamaphan, P., Starinskij, I., Jesudason, N., Shah, R., Sreenu, V. B., Stanton, T., Shaaban, S., MacLean, A., The COVID-19 Genomics UK (COG-UK) consortium, , Woolhouse, M., Gunson, R., Templeton, K., Thomson, E. C., Rambaut, A., Holden, M. T., Robertson, D. L.
10.1101/2021.01.08.20248677 — Posted: 2021-01-20
Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data
Cummings, L., Ebyarimpa, I., Cheetham, N., Tzortziou Brown, V., Brennan, K., Panovska-Griffiths, J.
10.1101/2021.01.19.20241844 — Posted: 2021-01-20
Seroepidemiological Study of Novel Corona Virus (CoVID-19) in Tehran, Iran
Tabanejad, Z., Darvish, S., Borjian Boroujeni, Z., Asadi, S. S., Mesri, M., Raiesi, O., Getso, M. I., Zareei, M.
10.1101/2021.01.18.20248911 — Posted: 2021-01-20
Immunisation, asymptomatic infection, herd immunity and the new variants of COVID-19
Grant, A., Hunter, P. R.
10.1101/2021.01.16.21249946 — Posted: 2021-01-20
Diagnosis of SARS-Cov-2 infection using specimens other than naso- and oropharyngeal swabs: a systematic review and meta-analysis
Moreira, V. M., Mascarenhas, P., Machado, V., Botelho, J., Mendes, J. J., Taveira, N., Almeida, M. G.
10.1101/2021.01.19.21250094 — Posted: 2021-01-20
A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assays
Klausberger, M., Duerkop, M., Haslacher, H., Wozniak-Knopp, G., Cserjan-Puschmann, M., Perkmann, T., Lingg, N., Aguilar, P. P., Laurent, E., De Vos, J., Hofer, M., Holzer, B., Stadler, M., Manhart, G., Vierlinger, K., Egger, M., Milchram, L., Gludovacz, E., Marx, N., Koeppl, C., Tauer, C., Beck, J., Maresch, D., Gruenwald-Gruber, C., Strobl, F., Satzer, P., Stadlmayr, G., Vavra, U., Huber, J., Wahrmann, M., Eskandary, F., Breyer, M.-K., Sieghart, D., Quehenberger, P., Leitner, G., Strassl, R., Egger, A. E., Irsara, C., Griesmacher, A., Hoermann, G., Weiss, G., Bellmann-Weiler, R., Loeffler-Ragg, J., Borth, N., Strasser, R., Jungbauer, A., Hahn, R., Mairhofer, J., Hartmann, B., Binder, N. B., Striedner, G., Mach, L., Weinhaeusl, A., Dieplinger, B., Grebien, F., Gerner, W., Binder, C. J., Grabherr, R.
10.1101/2021.01.19.21249921 — Posted: 2021-01-20
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: a randomised, placebo-controlled, dose-ranging study
Goepfert, P. A., Fu, B., Chabanon, A.-L., Bonaparte, M. I., Davis, M. G., Essink, B. J., Frank, I., Haney, O., Janosczyk, H., Keefer, M. C., Koutsoukos, M., Kimmel, M. A., Masotti, R., Savarino, S. J., Schuerman, L., Schwartz, H., Sher, L. D., Smith, J., Tavares-Da-Silva, F., Gurunathan, S., DiazGranados, C. A., DeBruyn, G.
10.1101/2021.01.19.20248611 — Posted: 2021-01-20
Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2
Collier, D., Meng, B., Ferreira, I., Datir, R., Temperton, N. J., Elmer, A., Graves, B., Kingston, N., McCoy, L., Smith, K., Bradley, J., Doffinger, R., Gupta, R.
10.1101/2021.01.19.21249840 — Posted: 2021-01-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).